Atropine Sulfate
Product Images NDC 0641-6006
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 0641-6006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
West-ward Logo (Atropine Sulfate Injection Usp 2)
This is a description of a pharmaceutical product called DG 0641-6006-0 Axonly which contains Atropine. It comes in a 20 mL multiple dose vial with a concentration of 0.4 mg in 8 mL of the solution. This medication is used for intramuscular, intravenous, or subcutaneous use under the supervision of a healthcare professional.*
Atropine Sulfate Injection, Usp 8 mg/20 mL (0.4 mg/ml) 20 mL Multiple Dose Vial (Atropine Sulfate Injection Usp 3)
This is a description of medication labeled as Sulfate Injection, its usual dosage is stated to be in the package insert and it can be administered through intramuscular, intravenous or subcutaneous method. The injection comes in the form of multiple dose vials which must be stored at room temperature. It is advised to use Alroplne Suluric Acdf if necessary to adjust the pH level. The text also mentions a specific dosage of 8mg per 20mL.*
Atropine Sulfate Injection, Usp 8 mg/20 mL (0.4 mg/ml) 10 X 20 mL Multiple Dose Vials (Atropine Sulfate Injection Usp 4)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.